217 related articles for article (PubMed ID: 31266501)
1. Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study.
Busson R; van der Kaaij M; Mounier N; Aleman BMP; Thiéblemont C; Stamatoullas A; Ribrag V; Tilly H; Haioun C; Casasnovas RO; Kluin-Nelemans HC; Henry-Amar M
Health Qual Life Outcomes; 2019 Jul; 17(1):115. PubMed ID: 31266501
[TBL] [Abstract][Full Text] [Related]
2. Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional study.
Mounier N; Anthony S; Busson R; Thieblemont C; Ribrag V; Tilly H; Haioun C; Casasnovas RO; Morschhauser F; Feugier P; Delarue R; Ysebaert L; Sebban C; Broussais-Guillaumot F; Damaj G; Nerich V; Jais JP; Laborde L; Salles G; Henry-Amar M
Cancer; 2019 Jul; 125(13):2291-2299. PubMed ID: 30901086
[TBL] [Abstract][Full Text] [Related]
3. Fatigue in male lymphoma survivors differs between diagnostic groups and is associated with latent hypothyroidism.
Kiserud CE; Seland M; Holte H; Fosså A; Fosså SD; Bollerslev J; Bjøro T; Loge JH
Acta Oncol; 2015 Jan; 54(1):49-59. PubMed ID: 25140862
[TBL] [Abstract][Full Text] [Related]
4. Persisting fatigue in Hodgkin lymphoma survivors: a systematic review.
Daniëls LA; Oerlemans S; Krol AD; van de Poll-Franse LV; Creutzberg CL
Ann Hematol; 2013 Aug; 92(8):1023-32. PubMed ID: 23728609
[TBL] [Abstract][Full Text] [Related]
5. Fatigue in long-term survivors of Hodgkin's lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG).
Rüffer JU; Flechtner H; Tralls P; Josting A; Sieber M; Lathan B; Diehl V;
Eur J Cancer; 2003 Oct; 39(15):2179-86. PubMed ID: 14522376
[TBL] [Abstract][Full Text] [Related]
6. Health-Related Quality of Life in Non-Hodgkin Lymphoma Survivors: A Prospective Cohort Study.
Kang D; Cho J; Kim IR; Kim MK; Kim WS; Kim SJ
Cancer Res Treat; 2018 Oct; 50(4):1051-1063. PubMed ID: 29121713
[TBL] [Abstract][Full Text] [Related]
7. Employment situation among long-term Hodgkin lymphoma survivors in Europe: an analysis of patients from nine consecutive EORTC-LYSA trials.
Juul SJ; Rossetti S; Kicinski M; van der Kaaij MAE; Giusti F; Meijnders P; Aleman BMP; Raemaekers JMM; Kluin-Nelemans HC; Spina M; Fermé C; Renaud L; Casasnovas O; Stamatoullas A; André M; Le Bras F; Plattel WJ; Henry-Amar M; Hutchings M; Maraldo MV
J Cancer Surviv; 2024 Jun; 18(3):727-738. PubMed ID: 36441393
[TBL] [Abstract][Full Text] [Related]
8. Persistent fatigue among long-term non-Hodgkin lymphoma survivors.
LeBlanc MR; Zimmerman S; LeBlanc TW; Bryant AL; Hudson KE; Smith SK
Leuk Lymphoma; 2022 Feb; 63(2):344-352. PubMed ID: 34612771
[TBL] [Abstract][Full Text] [Related]
9. Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group.
Kreissl S; Mueller H; Goergen H; Mayer A; Brillant C; Behringer K; Halbsguth TV; Hitz F; Soekler M; Shonukan O; Rueffer JU; Flechtner HH; Fuchs M; Diehl V; Engert A; Borchmann P;
Lancet Oncol; 2016 Oct; 17(10):1453-1462. PubMed ID: 27612583
[TBL] [Abstract][Full Text] [Related]
10. Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study.
Paunescu AC; Copie CB; Malak S; Gouill SL; Ribrag V; Bouabdallah K; Sibon D; Rumpold G; Preau M; Mounier N; Haioun C; Jardin F; Besson C
Ann Hematol; 2022 Feb; 101(2):317-332. PubMed ID: 34617134
[TBL] [Abstract][Full Text] [Related]
11. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
[TBL] [Abstract][Full Text] [Related]
12. Employment status and health related quality of life among Hodgkin-lymphoma survivors'- results based on data from a major treatment center in Hungary.
Magyari F; Kósa K; Berecz R; Illés A; Miltényi Z; Simon Z; Illés Á
Health Qual Life Outcomes; 2017 Sep; 15(1):180. PubMed ID: 28927453
[TBL] [Abstract][Full Text] [Related]
13. Patient-Reported Survivorship Care Practices and Late Effects After Treatment of Hodgkin and Non-Hodgkin Lymphoma.
Frick MA; Vachani CC; Hampshire MK; Bach C; Arnold-Korzeniowski K; Metz JM; Hill-Kayser CE
JCO Clin Cancer Inform; 2018 Dec; 2():1-10. PubMed ID: 30652594
[TBL] [Abstract][Full Text] [Related]
14. A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands.
Oerlemans S; Mols F; Issa DE; Pruijt JH; Peters WG; Lybeert M; Zijlstra W; Coebergh JW; van de Poll-Franse LV
Haematologica; 2013 Mar; 98(3):479-86. PubMed ID: 22929981
[TBL] [Abstract][Full Text] [Related]
15. Predictors of fatigue and poor sleep in adult survivors of childhood Hodgkin's lymphoma: a report from the Childhood Cancer Survivor Study.
Rach AM; Crabtree VM; Brinkman TM; Zeltzer L; Marchak JG; Srivastava D; Tynes B; Lai JS; Robison LL; Armstrong GT; Krull KR
J Cancer Surviv; 2017 Apr; 11(2):256-263. PubMed ID: 27837445
[TBL] [Abstract][Full Text] [Related]
16. FACTORS ASSOCIATED WITH INCREASED RED BLOOD CELLS TRANSFUSION REQUIREMENTS IN PATIENTS WITH HODGKIN AND NON-HODGKIN LYMPHOMA.
Ali S; Ali M; Badar F; Basit A; Hameed A
J Ayub Med Coll Abbottabad; 2015; 27(1):70-3. PubMed ID: 26182741
[TBL] [Abstract][Full Text] [Related]
17. The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin's and non-Hodgkin's lymphoma survivors: a systematic review.
Oerlemans S; Mols F; Nijziel MR; Lybeert M; van de Poll-Franse LV
Ann Hematol; 2011 Sep; 90(9):993-1004. PubMed ID: 21670973
[TBL] [Abstract][Full Text] [Related]
18. Association of social network and social support with health-related quality of life and fatigue in long-term survivors of Hodgkin lymphoma.
Soares A; Biasoli I; Scheliga A; Baptista RL; Brabo EP; Morais JC; Werneck GL; Spector N
Support Care Cancer; 2013 Aug; 21(8):2153-9. PubMed ID: 23475196
[TBL] [Abstract][Full Text] [Related]
19. Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors.
Vachon H; Mierzynska J; Taye M; Pe M; Coens C; Martinelli F; Fortpied C; Flechtner HH; Vestmoe Maraldo M; Hutchings M; Meijnders P; Aleman B; Lugtenburg P; Spina M; André M; Hertzberg M; Briones J; Bottomley A;
Eur J Haematol; 2021 May; 106(5):697-707. PubMed ID: 33570765
[TBL] [Abstract][Full Text] [Related]
20. Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study.
Dudley IM; Sunguc C; Heymer EJ; Winter DL; Teepen JC; Belle FN; Bárdi E; Bagnasco F; Gudmundsdottir T; Skinner R; Michel G; Byrne J; Øfstaas H; Jankovic M; Mazić MČ; Mader L; Loonen J; Garwicz S; Wiebe T; Alessi D; Allodji RS; Haddy N; Grabow D; Kaatsch P; Kaiser M; Maule MM; Jakab Z; Gunnes MW; Terenziani M; Zaletel LZ; Kuehni CE; Haupt R; de Vathaire F; Kremer LC; Lähteenmäki PM; Winther JF; Hjorth L; Hawkins MM; Reulen RC
Cancer; 2023 Feb; 129(3):426-440. PubMed ID: 36444554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
